Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Boehringer Ingelheim Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (87)
Cancellation by sponsor (44)
Prescription medicine registration (10)
Australian Public Assessment Report (AusPAR) (7)
Designation or determination (2)
Prescription medicine decision summary (1)
Prescription medicine evaluation (1)

Date

2024 (6)
2023 (9)
2022 (3)
2021 (6)
2020 (14)
2019 (2)
2018 (15)
2017 (4)
2016 (16)
2015 (13)
2014 (4)
2013 (14)
2012 (3)
2011 (8)
2010 (5)
2008 (4)
2007 (2)
2003 (1)
2002 (3)
2001 (4)
2000 (3)
1999 (7)
1998 (1)
1996 (1)
1993 (1)
1992 (1)
1991 (2)

Results for "[search-keyword]"

Search

Sponsor content

152 result(s) found, displaying 31 to 40

VIRAMUNE nevirapine 200mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 March 2021

Cancellation by sponsor

Requested by Boehringer Ingelheim Pty Ltd
OFEV, VARGATEF (Boehringer Ingelheim Pty Ltd)

23 December 2020

Prescription medicine registration

Active ingredients: nintedanib esilate.
PERSANTIN SR dipyridamole 200mg capsule bottle Cancelled under Section 30(1)(c) of the Act

30 November 2020

Cancellation by sponsor

Requested by Boehringer Ingelheim Pty Ltd
Boehringer Ingelheim Pty Ltd - Medication transfer set Cancelled under Section 41GL(d) of the Act

9 November 2020

Cancellation by sponsor

Requested by Boehringer Ingelheim Pty Ltd
Boehringer Ingelheim Pty Ltd - Medication transfer set (309505)

21 September 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Boehringer Ingelheim Pty Ltd - Medication transfer set.
Boehringer Ingelheim Pty Ltd - Medication transfer set (304750)

19 June 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Boehringer Ingelheim Pty Ltd - Medication transfer set.
PRITOR PLUS 80/12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2020

Cancellation by sponsor

Requested by Boehringer Ingelheim Pty Ltd
PRITOR PLUS 80/25mg telmisartan/hydrochlorothiazide tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2020

Cancellation by sponsor

Requested by Boehringer Ingelheim Pty Ltd
PRITOR PLUS 40/12.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2020

Cancellation by sponsor

Requested by Boehringer Ingelheim Pty Ltd
OFEV, VARGATEF (Boehringer Ingelheim Pty Ltd)

1 April 2020

Prescription medicine registration

Active ingredients: nintedanib esilate.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.